Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 7Phase 1/2 4Phase 3 3Phase 2/3 1

Status

Completed 35Active not recruiting 15Recruiting 7Unknown 3Terminated 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1CNS 1

Conditions

Sarcoma 1Head and Neck Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 129Radiotherapy 94Carboplatin 82Fluorouracil 77Paclitaxel 76Cyclophosphamide 76Gemcitabine 71Capecitabine 66Docetaxel 64Doxorubicin 59Oxaliplatin 57Etoposide 57Leucovorin 48Vincristine 46Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 23Methotrexate 21Rituximab 19Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Ipilimumab × Clear all
NCT04741438 2023-08-30

RAR-Immune

Centre Leon Berard

Phase 3 Unknown
96 enrolled
Sarcoma

Sarcoma

NCT03700905 2023-05-23

IMSTAR-HN

Universitätsklinikum Hamburg-Eppendorf

Phase 3 Unknown
276 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02460068 2015-06-02

NIBIT-M2

Italian Network for Tumor Biotherapy Foundation

Phase 3 Unknown
168 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡